Incidence analysis of six diseases in the national newborn screening program: a retrospective study from Adıyaman, Turkiye (2019-2023)
Open Access
- 28 October 2024
- journal article
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 6 (6) , 361-366
Abstract
Aims: This study aimed to determine the incidence of diseases included in the national newborn screening program in Adıyaman, Turkey, over the past five years and to evaluate the relative status of Adıyaman compared to national and global data. The study also sought to identify potential risk factors based on demographic variables. Methods: A retrospective, descriptive study was conducted in Adıyaman, Southeastern Turkey, analyzing heel blood sample data from 52,964 newborns between 2019 and 2023. The study excluded cases with unsuitable or retaken heel blood samples, partial biotinidase deficiency, and partial phenylalaninemia. Annual incidence rates were calculated based on confirmed diagnoses from relevant clinics. Results: The five-year incidence rates in Adıyaman were found to be higher than the national averages for phenylketonuria (1:2407), congenital hypothyroidism (1:582), biotinidase deficiency (1:481), cystic fibrosis (1:10593), congenital adrenal hyperplasia (1:5864), and spinal muscular atrophy (1:9489). No statistically significant differences were identified based on gender, birth weight, birth week, or maternal nationality, except for biotinidase deficiency, which was significantly higher in infants of Turkish mothers. Conclusion: The study highlights a higher incidence of screened diseases in Adıyaman than national averages, particularly biotinidase deficiency. Further research is recommended to investigate these findings and to address potential causes, such as consanguineous marriages.Keywords
This publication has 23 references indexed in Scilit:
- International Newborn Screening: Where Are We in Saudi Arabia?Journal of Epidemiology and Global Health, 2024
- Neonatal Screening for Congenital Adrenal Hyperplasia in Denmark: 10 Years of ExperienceHormone Research in Paediatrics, 2022
- PhenylketonuriaNature Reviews Disease Primers, 2021
- Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 yearsOrphanet Journal of Rare Diseases, 2021
- High frequency of biotinidase deficiency in Italian population identified by newborn screeningMolecular Genetics and Metabolism Reports, 2020
- The Genetic Landscape and Epidemiology of PhenylketonuriaThe American Journal of Human Genetics, 2020
- Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time PointsHormone Research in Paediatrics, 2020
- Newborn Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Glucose-6-Phosphate Dehydrogenase Deficiency for Improving Health Care in IndiaJournal of Pediatric Intensive Care, 2019
- The Current State of Newborn Screening in the United StatesPediatric Clinics of North America, 2019
- Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand, 1994–2013The Journal of Clinical Endocrinology & Metabolism, 2015